Evaluate TQ-A3334 Combined Nucleoside (Acid) Analogs in the First Treatment/Treatment of Chronic HBV Infection

NCT06706310 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

116

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: Placebo
DRUG: TQA3334 Tablet
DRUG: Nucleoside (acid) analogs (NAs)

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.